Osteosarcoma Institute is located in Dallas, TX. The organization was established in 2018. According to its NTEE Classification (H05) the organization is classified as: Research Institutes & Public Policy Analysis, under the broad grouping of Medical Research and related organizations. As of 12/2023, Osteosarcoma Institute employed 6 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Osteosarcoma Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Osteosarcoma Institute generated $1.4m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 6 years, the organization has seen revenues fall by an average of (27.3%) each year. All expenses for the organization totaled $2.7m during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Since 2020, Osteosarcoma Institute has awarded 31 individual grants totaling $4,800,449. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE MISSION OF THE OSTEOSARCOMA INSTITUTE IS TO DRAMATICALLY INCREASE TREATMENT OPTIONS AND SURVIVAL RATES IN OSTEOSARCOMA PATIENTS THROUGH IDENTIFYING AND FUNDING THE MOST PROMISING AND BREAKTHROUGH OSTEOSARCOMA CLINICAL TRIALS AND SCIENCE.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE OSTEOSARCOMA INSTITUTE EXECUTED AN AGREEMENT TO FUND A TRANSLATIONAL GRANT FOR A TOTAL OF $500,000 WITH EMORY UNIVERSITY. $250,000 OF THIS WAS FUNDED IN 2023.
THE OSTEOSARCOMA INSTITUTE EXECUTED AGREEMENTS TO FUND A TOTAL OF $560,000 FOR CORRELATIVE STUDY AND TRANSLATIONAL SCIENCE GRANT WITH THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO. $200,000 OF THIS WAS FUNDED IN 2023.
THE OSTEOSARCOMA INSTITUTE EXECUTED AGREEMENTS TO FUND TWO GRANTS FOR A TOTAL OF $1,300,000 FOR A CLINICAL TRIAL AND CORRELATIVE STUDY WITH THE DANA FARBER CANCER INSTITUTE. $355,000 OF THIS WAS FUNDED IN 2023.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Mchenry Tichenor Jr Chair Of Board Of Trustees | OfficerTrustee | 40 | $0 |
Mary Katherine Clarke Board Of Trustees | OfficerTrustee | 2 | $0 |
Lisa Tichenor Board Of Trustees | Trustee | 2 | $0 |
Lee Helman Institute Director | Officer | 16 | $240,915 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $1,258,050 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $1,258,050 |
Total Program Service Revenue | $0 |
Investment income | $111,384 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $1,369,434 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $1,424,320 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $250,000 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $240,915 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $306,916 |
Pension plan accruals and contributions | $9,127 |
Other employee benefits | $28,186 |
Payroll taxes | $27,661 |
Fees for services: Management | $70,375 |
Fees for services: Legal | $19,002 |
Fees for services: Accounting | $30,864 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $0 |
Advertising and promotion | $153,358 |
Office expenses | $14,992 |
Information technology | $29,306 |
Royalties | $0 |
Occupancy | $10,052 |
Travel | $23,021 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $82,246 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $4,516 |
All other expenses | $0 |
Total functional expenses | $2,748,118 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $777,919 |
Savings and temporary cash investments | $3,179,082 |
Pledges and grants receivable | $806,262 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $319 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $4,763,582 |
Accounts payable and accrued expenses | $45,345 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $45,345 |
Net assets without donor restrictions | $0 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $4,718,237 |
Total liabilities and net assets/fund balances | $4,763,582 |
Over the last fiscal year, Osteosarcoma Institute has awarded $1,424,320 in support to 10 organizations.
Grant Recipient | Amount |
---|---|
THE UNIVERSITY OF TEXAS - MD ANDERSON CANCER CENTER PURPOSE: CLINICAL TRIAL GRANT | $124,314 |
DANA FARBER CANCER INSTITUTE PURPOSE: CLINICAL TRIAL AND CORRELATIVE RESEARCH GRANTS | $355,000 |
REGENTS OF THE UNIVERSITY OF FLORIDA PURPOSE: CORRELATIVE STUDIES | $100,000 |
REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO PURPOSE: TRANSLATIONAL RESEARCH GRANTS | $200,000 |
RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL PURPOSE: TRANSLATIONAL RESEARCH GRANTS | $124,800 |
REGENTS OF EMORY UNIVERSITY PURPOSE: TRANSLATIONAL RESEARCH GRANTS | $250,000 |
Organization Name | Assets | Revenue |
---|---|---|
Metis Foundation San Antonio, TX | $3,717,155 | $12,069,658 |
Dallas Va Research Corporation Dallas, TX | $2,168,964 | $1,996,257 |
Osteosarcoma Institute Dallas, TX | $4,763,582 | $1,369,434 |
International Safety Center Inc League City, TX | $24,189 | $163,018 |
Lifeplus Foundation Batesville, AR | $50,261 | $68,591 |
Carnot Research Foundation Dallas, TX | $11,143 | $120,000 |
Childrens Optimal Health Austin, TX | $0 | -$123,152 |
Thomas-Mcmahan Cancer Foundation New Orleans, LA | $56,776 | -$462 |
International Veterinary Point-Of-Care Ultrasound Society Spicewood, TX | $56,671 | $0 |
Foundation Of Collaborative Unique Science Focus San Antonio, TX | $373,989 | $0 |
Center For Health And Economics Houston, TX | $0 | $0 |